ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Finasteride Could Save Many Years Of Life If Widely Used For Prostate Cancer Prevention

February 25, 2005

NCI-Approved Clinical Trials

May 30, 2003

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

Cancer Panel To Form Committee On Breast Cancer

October 11, 1991

Lymphoma Foundation Offers Research Grants

June 28, 1996